PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26742940-0	2016	Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse.	folfirinox	19-29	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	82-87	
26742940-7	2016	RESULTS: The survival analysis, carried out on 70 patients regardless of hENT1 expression, showed a statistically longer OS and PFS in the group treated with FOLFIRINOX compared to GEM.	folfirinox	158-168	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	73-78